Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;26(1):73-96.
doi: 10.1007/s11030-020-10158-3. Epub 2021 Jan 1.

Design, synthesis and SAR of antitubercular benzylpiperazine ureas

Sohal Satish  1 , Rohan Chitral  1 , Amitkumar Kori  1 , Basantkumar Sharma  1 , Jayashree Puttur  1 , Afreen A Khan  2 , Deepali Desle  2 , Kavita Raikuvar  2 , Aaron Korkegian  3 , Elvis A F Martis  2 , Krishna R Iyer  2 , Evans C Coutinho  2 , Tanya Parish  3 , Santosh Nandan  4
Affiliations

Design, synthesis and SAR of antitubercular benzylpiperazine ureas

Sohal Satish et al. Mol Divers. 2022 Feb.

Abstract

N-furfuryl piperazine ureas disclosed by scientists at GSK Tres Cantos were chosen as antimycobacterial hits from a phenotypic whole-cell screen. Bioisosteric replacement of the furan ring in the GSK Tres Cantos molecules with a phenyl ring led to molecule (I) with an MIC of 1 μM against Mtb H37Rv, low cellular toxicity (HepG2 IC50 ~ 80 μM), good DMPK properties and specificity for Mtb. With the aim of delineating the SAR associated with (I), fifty-five analogs were synthesized and screened against Mtb. The SAR suggests that the piperazine ring, benzyl urea and piperonyl moieties are essential signatures of this series. Active compounds in this series are metabolically stable, have low cellular toxicity and are valuable leads for optimization. Molecular docking suggests these molecules occupy the Q0 site of QcrB like Q203. Bioisosteric replacement of N-furfuryl piperazine-1-carboxamides yielded molecule (I) a novel lead with satisfactory PD, metabolism, and toxicity profiles.

Keywords: Antitubercular; Benzylpiperazine ureas; Lead compounds; QcrB inhibitors.

PubMed Disclaimer

References

    1. WHO Global Tuberculosis Report 2018 (2018). https://www.who.int/tb/publications/global_report/en/
    1. Rebollo-Lopez MJ, Lelievre J, Alvarez-Gomez D, Castro-Pichel J, Martinez-Jimenez F, Papadatos G, Kumar V, Colmenarejo G, Mugumbate G, Hurle M (2015) Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery. PLoS ONE 10(12):e0142293 - DOI
    1. Ballell L, Bates RH, Young RJ, Alvarez-Gomez D, Alvarez-Ruiz E, Barroso V, Blanco D, Crespo B, Escribano J, González R (2013) Fueling open-source drug discovery: 177 small-molecule leads against tuberculosis. ChemMedChem 8(2):313–321 - DOI
    1. Arora K, Ochoa-Montaño B, Tsang PS, Blundell TL, Dawes SS, Mizrahi V, Bayliss T, Mackenzie CJ, Cleghorn LA, Ray PC (2014) Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis. Antimicrob Agents Chemother 58(11):6962–6965 - DOI
    1. Foo CS, Lupien A, Kienle M, Vocat A, Benjak A, Sommer R, Lamprecht DA, Steyn AJ, Pethe K, Piton J (2018) Arylvinylpiperazine amides, a new class of potent inhibitors targeting QcrB of mycobacterium tuberculosis. MBio 9(5):e01276-01218 - DOI

MeSH terms

LinkOut - more resources